CD163 and cervical carcinoma: Interestingly, our results showed a strong association correlation between CD163 + CD204 + M2TAM, via STAT3/NF-κB pathways and the expression of CD25, FOXP3, MIF, and IL-17 in 56.2%, 76.3%, 85.2%, and 86.1%, respectively, of 691 patients with cervical cancer.